{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "D839Y",
      "SARS-CoV-2",
      "Spike",
      "fusion peptide",
      "genetic variant",
      "genomic epidemiology",
      "mutation"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33131453",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1080/22221751.2020.1844552"
    ],
    "Journal": {
      "ISSN": "2222-1751",
      "JournalIssue": {
        "Volume": "9",
        "Issue": "1",
        "PubDate": {
          "Year": "2020",
          "Month": "Dec"
        }
      },
      "Title": "Emerging microbes & infections",
      "ISOAbbreviation": "Emerg Microbes Infect"
    },
    "ArticleTitle": "Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal.",
    "Pagination": {
      "StartPage": "2488",
      "EndPage": "2496",
      "MedlinePgn": "2488-2496"
    },
    "Abstract": {
      "AbstractText": [
        "Genomic surveillance of SARS-CoV-2 was rapidly implemented in Portugal by the National Institute of Health in collaboration with a nationwide consortium of >50 hospitals/laboratories. Here, we track the geotemporal spread of a SARS-CoV-2 variant with a mutation (D839Y) in a potential host-interacting region involving the Spike fusion peptide, which is a target motif of anti-viral drugs that plays a key role in SARS-CoV-2 infectivity. The Spike Y839 variant was most likely imported from Italy in mid-late February and massively disseminated in Portugal during the early epidemic, becoming prevalent in the Northern and Central regions of Portugal where it represented 22% and 59% of the sampled genomes, respectively, by 30 April. Based on our high sequencing sampling during the early epidemics [15.5% (1275/8251) and 6.0% (1500/24987) of all confirmed cases until the end of March and April, respectively], we estimate that, between 14 March and 9 April (covering the epidemic exponential phase) the relative frequency of the Spike Y839 variant increased at a rate of 12.1% (6.1%-18.2%, CI 95%) every three days, being potentially associated with 24.8% (20.8-29.7%, CI 95%; 3177-4542 cases, CI 95%) of all COVID-19 cases in Portugal during this period. Our data supports population/epidemiological (founder) effects contributing to the Y839 variant superspread. The potential existence of selective advantage is also discussed, although experimental validation is required. Despite huge differences in genome sampling worldwide, SARS-CoV-2 Spike D839Y has been detected in 13 countries in four continents, supporting the need for close surveillance and functional assays of Spike variants."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0003-3767-2209"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal."
          }
        ],
        "LastName": "Borges",
        "ForeName": "V\u00edtor",
        "Initials": "V"
      },
      {
        "Identifier": [
          "0000-0002-8529-9878"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal."
          }
        ],
        "LastName": "Isidro",
        "ForeName": "Joana",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Reference and Surveillance Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal."
          }
        ],
        "LastName": "Cortes-Martins",
        "ForeName": "Helena",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Innovation and Technology Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal."
          }
        ],
        "LastName": "Duarte",
        "ForeName": "S\u00edlvia",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Innovation and Technology Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal."
          },
          {
            "Identifier": [],
            "Affiliation": "Centre for Toxicogenomics and Human Health (ToxOmics), Genetics, Oncology and Human Toxicology, Nova Medical School Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal."
          }
        ],
        "LastName": "Vieira",
        "ForeName": "Lu\u00eds",
        "Initials": "L"
      },
      {
        "Identifier": [
          "0000-0002-9622-3895"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto Gulbenkian de Ci\u00eancia (IGC), Oeiras, Portugal."
          }
        ],
        "LastName": "Leite",
        "ForeName": "Ricardo",
        "Initials": "R"
      },
      {
        "Identifier": [
          "0000-0003-1622-5143"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto Gulbenkian de Ci\u00eancia (IGC), Oeiras, Portugal."
          }
        ],
        "LastName": "Gordo",
        "ForeName": "Isabel",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Epidemiology, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal."
          }
        ],
        "LastName": "Caetano",
        "ForeName": "Constantino P",
        "Initials": "CP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Epidemiology, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal."
          },
          {
            "Identifier": [],
            "Affiliation": "Centro de Investiga\u00e7\u00e3o em Sa\u00fade P\u00fablica, Escola Nacional de Sa\u00fade P\u00fablica, Universidade Nova de Lisboa, Lisbon, Portugal."
          }
        ],
        "LastName": "Nunes",
        "ForeName": "Baltazar",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Public Health Unit, Primary Care Cluster of Baixo Vouga, Central Regional Health Administration, Aveiro, Portugal."
          }
        ],
        "LastName": "S\u00e1",
        "ForeName": "Regina",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Public Health Unit, Primary Care Cluster of Baixo Vouga, Central Regional Health Administration, Aveiro, Portugal."
          }
        ],
        "LastName": "Oliveira",
        "ForeName": "Ana",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "National Reference Laboratory for Influenza and other Respiratory Viruses, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal."
          }
        ],
        "LastName": "Guiomar",
        "ForeName": "Raquel",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal."
          }
        ],
        "CollectiveName": "Portuguese network for SARS-CoV-2 genomics"
      },
      {
        "Identifier": [
          "0000-0002-2697-2399"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge (INSA), Lisbon, Portugal."
          }
        ],
        "LastName": "Gomes",
        "ForeName": "Jo\u00e3o Paulo",
        "Initials": "JP"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Emerg Microbes Infect",
    "NlmUniqueID": "101594885",
    "ISSNLinking": "2222-1751"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology",
        "transmission",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Epidemiological Monitoring"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genome, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genomics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "High-Throughput Nucleotide Sequencing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Phylogeny"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Portugal"
    },
    {
      "QualifierName": [
        "classification",
        "genetics",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Severity of Illness Index"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    }
  ],
  "CoiStatement": "No potential conflict of interest was reported by the author(s)."
}